Management strategies for hepatitis B–infected patients undergoing immunomodulatory therapy: Is lamivudine enough?

Publisher： John Wiley & Sons Inc

E-ISSN： 2046-2484|5|2|43-46

ISSN： 2046-2484

Source： CLINICAL LIVER DISEASE (ELECTRONIC), Vol.5, Iss.2, 2015-02, pp. : 43-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis B reactivation from immunosuppressive drug therapy: A global menace: Editor's comment for february issue of clinical liver disease

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 5, Iss. 2, 2015-02 ,pp. : 39-42

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of patients with hepatitis C virus resistance–associated variants to NS5A inhibitors: Where are we now?

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 4, 2015-10 ,pp. : 82-85

John Wiley & Sons Inc

Access to resources Recommend Favorite

Processing Strategies to Inactivate Hepatitis A Virus in Food Products: A Critical Review

By  

COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY, Vol. 14, Iss. 6, 2015-11 ,pp. : 771-784

John Wiley & Sons Inc

Access to resources Recommend Favorite

ApoE Levels in Patients Undergoing CPB

By  

ARTIFICIAL ORGANS, Vol. 39, Iss. 1, 2015-01 ,pp. : 28-33

John Wiley & Sons Inc

Access to resources Recommend Favorite

Searching for biomarkers of comorbidities in sera of treated HIV‐infected patients by isoelectric focusing

By  

ELECTROPHORESIS, Vol. 36, Iss. 11-12, 2015-06 ,pp. : 1251-1255

John Wiley & Sons Inc

Access to resources Recommend Favorite